1.The East Asian gut microbiome and its role in oncology: a narrative review.
Evelyn Yi Ting WONG ; Jonathan Wei Jie LEE ; Jeremy Fung Yen LIM ; Han Chong TOH
Singapore medical journal 2025;66(8):426-430
The field of onco-microbiome is rapidly expanding. Multiple studies have shown the crucial role of gut microbiota in the regulation of nutrient metabolism, immunomodulation and protection against pathogens. Tools for manipulating the gut microbiota include dietary modification and faecal microbiota transfer. Accumulating evidence has also documented the application of specific intestinal microbiome in cancer immunotherapy, notably in enhancing the efficacy of immune checkpoint inhibitors. The aim of this review is to focus on the East Asian microbiome and to provide a current overview of microbiome science and its clinical application in cancer biology and immunotherapy.
Humans
;
Gastrointestinal Microbiome
;
Neoplasms/microbiology*
;
Immunotherapy/methods*
;
Asia, Eastern
;
Medical Oncology
;
Fecal Microbiota Transplantation
;
Immune Checkpoint Inhibitors/therapeutic use*
;
East Asian People
2.Public knowledge, awareness and perception of gut microbiome and faecal microbiota transplantation in Singapore: a survey study.
Lydia Wan Zhen LIM ; Kai Yee TOH ; Alex Richard COOK ; Jonathan Wei Jie LEE ; Jeremy Fung Yen LIM
Singapore medical journal 2025;66(8):439-448
INTRODUCTION:
Despite the exponential increase in microbiome research, knowledge and beliefs about the gut microbiome and faecal microbiota transplantation (FMT) remain unclear. The aim of this study was to identify the extent of knowledge, awareness and perception among the general public regarding the gut microbiome and FMT.
METHODS:
An online questionnaire on knowledge and beliefs about the gut microbiome and FMT was administered to 1831 participants. Data analysis software was used to generate descriptive statistics and explore associations between knowledge and sociodemographic variables.
RESULTS:
Even though only 33% of participants had heard of the gut microbiome, more than 92% had consumed probiotic drinks or supplements. While 85% had not heard of the FMT procedure, 72% of respondents would consider having FMT to treat Clostridioides difficile infection (CDI). Willingness to receive FMT depended mainly on recommendation from healthcare providers (77%). Knowledge and awareness regarding the gut microbiome and FMT were relatively low, despite most participants having prior gut health-related behaviours.
CONCLUSION
This study identified the public's perceptions of FMT and the potential barriers to its uptake. Insights from the study highlight the need for health education to enhance acceptance of FMT and the importance of using information supported by medical professionals to immunise the public against poorly validated science.
Humans
;
Fecal Microbiota Transplantation
;
Health Knowledge, Attitudes, Practice
;
Male
;
Female
;
Singapore
;
Gastrointestinal Microbiome
;
Surveys and Questionnaires
;
Adult
;
Middle Aged
;
Young Adult
;
Aged
;
Clostridium Infections/therapy*
;
Adolescent

Result Analysis
Print
Save
E-mail